Lifecycle regulation of narrow therapeutic index drugs: Chinese practices, international benchmarks, and optimization pathways
Crossref DOI link: https://doi.org/10.1007/s00210-026-04996-5
Published Online: 2026-01-19
Published Print: 2026-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Xuelin
Qian, Dongfang
Zhao, Wenjing
Hu, Xin
Zhang, Yatong
Text and Data Mining valid from 2026-01-19
Version of Record valid from 2026-01-19
Article History
Received: 24 September 2025
Accepted: 8 January 2026
First Online: 19 January 2026
Declarations
:
: Not applicable.
: The authors declare no competing interests.